Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2012
03/22/2012WO2012037116A2 Common and rare genetic variations associated with common variable immunodeficiency (cvid) and methods of use thereof for the treatment and diagnosis of the same
03/22/2012WO2012037078A2 Immunogenic respiratory syncytial virus glycoprotein-containing vlps and related compositions, constructs, and therapeutic methods
03/22/2012WO2012037043A2 Treatment of autoimmune inflammation using mir-155
03/22/2012WO2012037015A2 Novel lactobacillus salivarius and novel bacteriocin
03/22/2012WO2012036437A2 Immunogenic peptide and composition having the peptide for preventing or treating hpv-related disease
03/22/2012WO2012036433A2 Treatment of neurodegenerative diseases by targeting mirna
03/22/2012WO2012036412A2 Peptide having a vascularization-suppressing activity and a use therefor
03/22/2012WO2012036410A2 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
03/22/2012WO2012036191A1 Composition for improving brain function and method for improving brain function
03/22/2012WO2012035871A1 Brain function enhancement composition and method for enhancing brain function
03/22/2012WO2012035113A1 Type-1 interferons for treatment of multiple sclerosis
03/22/2012WO2012035088A1 Na+/Mg2+ exchanger
03/22/2012WO2012034704A1 Treatment of vascular diseases using encapsulated cells encoding and secreting glp-1, or a fragment or variant thereof
03/22/2012WO2012034360A1 Insulin crystal microsphere, suspension and preparation method thereof
03/22/2012WO2012034197A1 Synthetic gene for expressing sm-14 in pichia pastoris, methods for producing and purifying sm-14 and the use thereof as a vaccine and diagnostic medium
03/22/2012WO2012034188A1 Peptide inhibitors of cd40l signaling and uses therefor
03/22/2012WO2012009631A8 Humanized antibodies targeting the ec1 domain of cadherin-11 and related compositions and methods
03/22/2012WO2012007658A3 Use of the pat nonapeptide in treating and preventing neurodegenerative diseases
03/22/2012WO2012006556A3 Analyte detection using proximity probes
03/22/2012WO2011163593A3 Induction of immune response
03/22/2012WO2011159882A3 Novel stabilized insulin agonists
03/22/2012WO2011152618A9 Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof
03/22/2012WO2011149964A9 Methods for treating or preventing vascular graft failure
03/22/2012WO2011142858A9 Chlorotoxin variants, conjugates, and methods for their use
03/22/2012WO2011128892A3 Modified forms of pneumococcal surface immunogenic protein b (psipb)
03/22/2012WO2011120474A9 Method for inhibiting hiv replication in mammal and human cells
03/22/2012WO2011116286A3 Stable bortezomib formulations
03/22/2012WO2011115447A9 C-terminal truncated peroxiredoxin-ii, and composition for preventing and treating apoptosis containing same
03/22/2012WO2011110948A3 Process,tube and device for the preparation of wound healant composition
03/22/2012WO2011083481A3 Method for treatment of inflammatory disease and disorder
03/22/2012US20120071817 Stabilized glucagon solutions and uses therefor
03/22/2012US20120071704 Mitochondrial localization of muc1
03/22/2012US20120071545 Compositions and methods for treatment of bacterial and mycobacterial infections
03/22/2012US20120071538 Pharmaceutical formulatons
03/22/2012US20120071422 Therapeutic application of isolated naturally-occuring soluble truncated forms of IL-23 receptor
03/22/2012US20120071421 Therapy with clostridium perfringens enterotoxin to treat ovarian and uterine cancer
03/22/2012US20120071420 Modified t cell receptors and related materials and methods
03/22/2012US20120071419 Target-Specific Non-Antibody Protein and Method for Preparing the Same
03/22/2012US20120071418 Inhibitors of Human EZH2 and Methods of Use Thereof
03/22/2012US20120071417 Methods of inhibiting cancer cell growth with hdac inhibitors and methods of screening for hdac10 inhibitors
03/22/2012US20120071416 Low frequency glatiramer acetate therapy
03/22/2012US20120071415 Dominant negative mutants of sam68 for use in the treatment of spinal muscular atrophy (sma)
03/22/2012US20120071414 Method for producing and using active principles of limestone
03/22/2012US20120071413 TREATMENT OF CHRONIC NEPHROPATHIES USING SOLUBLE COMPLEMENT RECEPTOR TYPE I (sCR1)
03/22/2012US20120071412 Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders
03/22/2012US20120071411 Lkktet and/or lkktnt peptide compositions which are lyophilized or in a form capable of being lyophilized
03/22/2012US20120071410 Calcitonin products and therapies for treating inflammatory or degenerative diseases
03/22/2012US20120071409 Colloidal Liposomal Compositions and Methods
03/22/2012US20120071408 Formulations for achieving weight loss
03/22/2012US20120071407 Method of treating wounds
03/22/2012US20120071406 Modified vegf-a with improved angiogenic properties
03/22/2012US20120071405 Composition of inhibiting pathological angiogenesis
03/22/2012US20120071404 Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
03/22/2012US20120071403 Methods for Treating Type 2 Diabetes in Patients Resistant to Previous Treatment with other Anti-Diabetic Drugs Employing an SGLT2 Inhibitor and Compositions Thereof
03/22/2012US20120071402 Protease Stabilized, Pegylated Insulin Analogues
03/22/2012US20120071401 Amylin agonist compounds for estrogen-deficient mammals
03/22/2012US20120071400 Lipid metabolism-improving reagent
03/22/2012US20120071399 Sulfation of wnt pathway proteins
03/22/2012US20120071398 Anti-microbial peptides
03/22/2012US20120071397 Methods for Hematopoietic Stem Cell Transplantation
03/22/2012US20120071396 Compositions and Methods for Inhibiting the Interaction Between CFTR and CAL
03/22/2012US20120071395 TREATMENT OF MAMMALIAN PHYSIOLOGICAL REACTION OF IgE ANTIBODIES PRESENT IN SAID MAMMAL UPON CONTACT WITH THE CORRESPONDEING ANTIGEN
03/22/2012US20120071394 Novel polypeptides and use thereof
03/22/2012US20120071393 Mutant CyaA Polypeptides and Polypeptide Derivatives Suitable for the Delivery of Immunogenic Molecules Into a Cell
03/22/2012US20120070513 Method and Composition for Treating Diabetic Ketoacidosis
03/22/2012US20120070511 Mitochondrial inhibitors and uses thereof
03/22/2012US20120070504 Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
03/22/2012US20120070497 Use of boswellic acids for the prophylaxis and/or treatment of damage to and/or inflammation of the islets of langerhans
03/22/2012US20120070490 Anti-trypanosomal peptides and uses thereof
03/22/2012US20120070489 Combination therapy for treatment of fiv infection
03/22/2012US20120070487 Alkylsaccharide compositions with nutraceuticals
03/22/2012US20120070486 Methods and compositions related to prefoldin and its regulation
03/22/2012US20120070485 method for producing a device applicable to biological tissues, particularly a patch for treating damaged tissues, and a device obtained by said method
03/22/2012US20120070483 Multi-Functional Biocompatible Coatings for Intravascular Devices
03/22/2012US20120070477 Dry powder fibrin sealant
03/22/2012US20120070474 Polymer compound for biomedical use and biochip substrate using such a polymer compound
03/22/2012US20120070471 Administration of enoxoparin sodium to patients 75 years and older with st-segment elevation myocardial infarction
03/22/2012US20120070469 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
03/22/2012US20120070467 Ophthalmic Drug Delivery
03/22/2012US20120070466 Conjugated Polymeric Material and Uses Thereof
03/22/2012US20120070460 Dendritic cell modulatory molecule
03/22/2012US20120070456 Polypeptide carrier protein
03/22/2012US20120070452 Immunoadjuvant composition and use thereof
03/22/2012US20120070451 Methods and compositions for modulating cardiac contractility
03/22/2012US20120070449 Methods of treating inflammation
03/22/2012US20120070445 Brain-derived gonadotropins and cognition
03/22/2012US20120070444 IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
03/22/2012US20120070443 Pde1 as a target therapeutic in heart disease
03/22/2012US20120070441 Extracellular yaluronidase from streptomyces koganeiensis
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/22/2012US20120070427 Vortex-induced silk fibroin gelation for encapsulation and delivery
03/22/2012US20120070425 TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC Beta-CELL DYSFUNCTION AND FOR Beta-CELL PROLIFERATION
03/22/2012US20120070424 Mutations on OAS1 Genes
03/22/2012US20120070423 Oral composition and method of forming and using same
03/22/2012US20120070417 Anti-influenza formulations and methods
03/22/2012US20120070416 Macrocyclic Proline Derived HCV Serine Protease Inhibitors
03/22/2012US20120070415 Azido nucleosides and nucleotide analogs
03/22/2012US20120070414 Controlling disease vectors from insects and arthropods using preconidial mycelium and extracts of preconidial mycelium from entomopathogenic fungi
03/22/2012US20120070413 Method of treating cancer with substituted amide derivatives
03/22/2012US20120070412 HCV Inhibitor and Therapeutic Agent Combinations
1 ... 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 ... 3163